Latest News in the pharma Industry
Biopharma News
Catalent boosts plasmid DNA manufacturing at Rockville with addition of ABEC fermenters
7 Apr 2021
The company's custom single run single-use fermenters supplied on fast-track schedule to support flexible manufacturing of plasmid DNA
Read more
Bavarian Nordic receives $28 million Ebola vaccine order from J&J
7 Apr 2021
The smallpox vaccine specialist will manufacture and deliver bulk drug substance of MVA-BN Filo vaccine during the second half of this year
Read more
Moderna and Catalent expand COVID vaccine manufacturing agreement
6 Apr 2021
The extended collaboration comes after reaching the initial milestone of producing 100 million doses
Read more
Sterling Pharma seals acquisition of bioconjugation specialist ADC
6 Apr 2021
By integrating its HPAPI capabilities with those at ADC Biotechnologies' Deeside facility, small molecule CDMO will be able to offer the development and manufacturing of toxin linkers
Read more
TCR2 bets on lead candidate with new cell therapy manufacturing facility
30 Mar 2021
The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel
Read more
Lonza to support Pionyr Immunotherapeutics' oncology drug development
30 Mar 2021
The CDMO will provide cell line development, process development, drug substance and drug product manufacturing for Pionyr’s monoclonal antibody candidate
Read more
CPhI Webinar Series: Latest Approaches for Large Volume Drug Delivery
26 Mar 2021
Innovation in the design and development of large volume drug delivery devices can solve the challenge of accommodating the increasing trend towards patient self-administration and home care while at the same time ensuring that drugs that require intra...
Read more
Fujifilm names North Carolina as location for $2 billion large-scale cell manufacturing site
19 Mar 2021
CDMO subsidiary Fujifilm Diosynth Biotechnologies will operate the site which is expected to be operational in 2025
Read more
Pfizer to sell Chinese biologics manufacturing facility to WuXi
17 Mar 2021
Multinational makes ‘difficult decision’ to halt presence in Chinese biosimilars market five years after $350 million investment
Read more
Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges
16 Mar 2021
Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year
Read more
Special Podcast: CPhI Outlook Roundtable - Listen Now
9 Mar 2021
In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, Bi...
Read more
Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence
9 Mar 2021
Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the...
Read more